CIK: 1238971 - Address: C/o Osi Pharmaceuticals, Inc., 41 Pinelawn Road, Melville, NY 11747
40 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

8/3/05 13:56
8/1/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDM.d2516.8102724D
8/3/05 13:56
8/1/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDS.d-6341.740-2-304D
7/6/05 10:43
7/1/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDM.d2516.8102724D
7/6/05 10:43
7/1/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDS.d-6040.000-2-304D
6/17/05 15:54
6/16/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDM.d2516.8102724D
6/17/05 15:54
6/16/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDS.d-6040.000-2-304D
5/3/05 16:54
5/2/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDM.d2516.8102724D
5/3/05 16:54
5/2/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDS.d-7147.450-2-304D
4/4/05 13:01
4/1/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDM.d2516.8102724D
4/4/05 13:01
4/1/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDS.d-6241.400-2-304D
3/3/05 16:34
3/1/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDM.d2516.81021083D
3/3/05 16:34
3/1/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDS.d-8153.980-2-343D
2/3/05 16:13
2/1/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDM.d2516.81021083D
2/3/05 16:13
2/1/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDS.d-9865.120-2-343D
1/5/05 17:10
1/3/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDM.d2516.81021083D
1/5/05 17:10
1/3/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDS.d-11173.970-2-343D
12/3/04 16:40
12/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDM.d2516.81021083D
12/3/04 16:40
12/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDS.d-7248.320-2-343D
10/5/04 14:39
10/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDM.d816.8101213D
10/5/04 14:39
10/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDS.d-3161.090-1-153D
9/2/04 17:07
9/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDM.d2416.81011013D
9/2/04 17:07
9/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDS.d-8659.150-1-333D
8/4/04 16:47
8/2/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDM.d2416.81011013D
8/4/04 16:47
8/2/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDS.d-8458.170-1-333D
7/2/04 16:18
7/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDM.d2416.81011013D
7/2/04 16:18
7/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDS.d-10169.880-1-333D
6/3/04 17:45
6/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDM.d2416.81011013D
6/3/04 17:45
6/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDS.d-11881.270-1-333D
5/5/04 17:23
5/3/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDM.d2416.81011013D
5/5/04 17:23
5/3/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDS.d-10673.380-1-333D
4/2/04 16:25
4/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDM.d2416.81011013D
4/2/04 16:25
4/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDS.d-5538.270-1-333D
3/1/04 16:18
3/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDM.d2416.81012302D
3/1/04 16:18
3/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDS.d-4732.470-1-412D
2/3/04 15:42
2/2/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDM.d2416.81012302D
2/3/04 15:42
2/2/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDS.d-5034.730-1-412D
1/6/04 09:53
1/2/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDM2416.81012302D
1/6/04 09:53
1/2/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDS-4732.160-1-412D
12/17/03 13:57
12/15/03
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDM2416.81012302D
12/17/03 13:57
12/15/03
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticRichmond MarkNYDS-4531.070-1-412D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact